MedPage Today on MSN
First Drug for Deadly Transplant Complication Gets FDA's Blessing
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
Exercise caution. Your competitive spin class could be setting the wheels in motion for a serious health issue that’s become increasingly common.
Novartis’ ITVISMA, approved a month ago by the US FDA, used at Sheikh Khalifa Medical City under the supervision of the ...
SB Nation on MSN
Yankees Potential Trade Target: Nick Lodolo
Finally, the Yankee system balances young bats and arms well. George Lombard Jr. is probably not going to be dealt, but ...
Botanic Tonics’ supplement drinks have taken convenience stores by storm—even as the company has battled allegations of ...
The Morning Journal on MSN
Keystone grad Gideon Lampron prepares to test transfer portal after successful year at Bowling Green
In 2025, Keystone grad Gideon Lampron was set to prove he belonged in the Mid-American Conference — a stage he thought was ...
Follow our live cricket update for in-depth match coverage and exciting highlights from Australia vs England 4th Test at ...
The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...
Tuesday marked the first time Flagg’s brothers sat courtside to watch him play an NBA game, and they picked a good one.
Genesis HealthCare used bankruptcy to avoid paying families after settling lawsuits over neglect, including cases with maggot ...
Novo Nordisk just got a big win from the FDA, and it could change the weight-loss medicine industry again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results